Skip to main content
Iranian Journal of Pharmaceutical Research : IJPR logoLink to Iranian Journal of Pharmaceutical Research : IJPR
. 2010 Autumn;9(4):429–436.

Biological Screening of Euphorbia Aellenii

Abdul Majid Ayatollahi a, Mustafa Ghanadian b, Suleiman Afsharypuor b, Sadia Siddiq c, Seyed Muhammad Pour-Hosseini d
PMCID: PMC3870068  PMID: 24381609

Abstract

Fractions obtained from partitioning of aerial methanolic extract of Euphorbia Aelleniiwith chloroform (E2), ethyl acetate (E3), n-butanol (E4) and water (E5) were investigated in vitro for their phytotoxicity, insecticidal, anti-leishmanial, cytotoxicity, antibacterial and antifungal activities. Sample E2 appeared to have significant phytotoxic activity. In the insecticidal screening study only one of the insects, Rhyzopertha dominica, showed acceptable mortality after treatment with E2, but weak response to E3 and E4 fractions. Leishmanicidal activity of the chloroform fraction was present, but not very significant. E2 showed favorable cytotoxic activity, while E3 had weak activity, and the other samples had no significant activity. In the antifungal screening tests; E2, E3 and E4 fractions exhibited about 25% inhibition of fungal growth against Fusariumsolani, while they were not active against other tested fungi. The results of antibacterial screening were completely negative, which may be due to resistance towards these types of constituents.

Key Words: Euphorbia Aellenii, Phytotoxicity activity, Insecticidal activity, Anti-leishmanial activity, Cytotoxicity activity, Antibacterial activity, Antifungal activity

Introduction

Euphorbiaceae is one of the largest families of the phylum Anthophyta. In this family, the largest genus is Euphorbia, which comprises well over 2000 species, grows in the form of laticiferous herbs, shrubs, and small trees, inhabiting the tropical and temperate zones of Asia and other parts of the world (1). For centuries, plants and plant materials of Euphorbia have been known to be poisonous to human beings. Often they are held responsible for the poisoning of livestock and are used as arrow poisons. In traditional medicine, it was used as treatment of intestinal parasites, gonorrhea and in treatment of skin diseases (2, 3). However, multidisciplinary pharmacological screening carried out on a variety of ailments like cancer, rheumatism, neuralgia, asthma, and bacterial infections (2) and its latex is one the remedies used topically to treat the coetaneous leishmaniasis (4, 5). Therefore, secondary bioactive metabolites of this plant seem to be active against a wide range of assay targets. Thus, plant extracts suggested to screened for general biologic activities, throw out the negatives and then run specific bioassays on actives, the active fractions selected, and the bioactive compounds isolated and identified.

In this research Euphorbia Aellenii, a perennial plant growing in some parts of Iran (6), was selected to perform bioassay tests as a guide for selection of bioactive fractions to avoid the risk of wasting time and purification of undesired compounds. The following six bioassays:

phytotoxicity, insecticidal antileishmanial, cytotoxicity, antibacterial and antifungal activity, focused on pharmacological and folk medicine rationales, as inexpensive, rapid, and simple top-benched general bioassays were applied as a strategy for screening, fractionation and monitoring of physiologically active natural products in this plant.

Experimental

Plant material

The whole plant of Euphorbia aellenii (Euphorbiaceae) was collected in August 2007 from populations growing in Galil-e-Shirvan (near the Turkmenistan border), Northern Khorasan province, Iran. The plant was identified by Mrs. Yasamin Naseh, plant taxonomist (Department of Botany, Herbaceous Sciences Research Center, Ferdowsi University, Mashhad, Iran). A voucher specimen of the plant was deposited in the herbarium of the Pharmacognosy Department, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Iran.

Extraction and isolation

The dried plant (7 Kg) was extracted three times with MeOH (20 L) at room temperature for 4 days and the resulting extract was then concentrated to a dark green gum. The gummy residue (500 g) partitioned between n-hexane and MeOH. The defatted MeOH extract was evaporated and dissolved in water to make a suspension and then partitioned with different solvents including chloroform, ethyl acetate and n-butanol, respectively. Four fractions, which were the chloroform (E2), ethyl acetate (E3), n-butanolic (E4) and aqueous (E5) samples were obtained and subsequently investigated for different biological activities.

Phytotoxic activity

In order to conduct the Lemna minor method for phytotoxicity assay, an inorganic medium was prepared by mixing various inorganic constituents in 1 L distilled water, adjustment of pH between 5.5 to 6.0 using KOH, and autoclaving the medium at 121oC for 15 min.

Next, weighed 15 mg samples of E2, E3, E4, E5, as well as paraquat (N, N′-dimethyl-4, 4′- bipyridinium dichloride) as the standard herbicide agent were individually dissolved in 15 mL of ethanol, and used as stock solutions. Then 1000 mL , 100 mL and 10 mL increments of these stock solutions were added into different vials and after overnight evaporation of the solvent, 2mL of the prepared medium was added into each vial to make concentrations of 500, 50 and 5 ppm, respectively. After that a single fresh, green plant containing a rosette of three fronds was added to every vial. They were then individually placed in a Petri dish filled with about 2 cm of water, and sealed with greasy glass plate. Petri dishes were then placed in the growth chamber for one week at 28 ± 1°C, under a fluorescent lamp. The number of fronds per vial were counted and recorded on the seventh day (7). The results were calculated using the following equation and with reference to paraquat as the standard herbicidal agent, as well as the volatile solvent as the negative control (7):

% Regulation = 100 – Number of fronds in the test sample × 100 Number of fronds in – the negative control

The criteria used were as follows: 0-39% inhibition (low activity), 40-59% inhibition (moderate activity), 60-69% inhibition (good activity), above 70% inhibition (significant activity).

Insecticidal activity

Samples E2, E3, E4 and E5 were evaluated against different insects. At first, samples were prepared by dissolving 200 mg of each sample, individually, in 3 mL ethanol. Next, filter papers impregnated with these sample solutions, a concentration of 1 mg/cm2, were prepared and left intact for 24 h for solvent evaporation. From every insect, ten adult insects were transferred to Petri dishes covered by the impregnated filter papers. This procedure was also performed for the negative control (without any sample) and the positive control (using permethrin as the standard agent at a concentration of 239.5 μg/cm2 of filter paper). The survival of insects after 24 h of direct contact with the filer paper impregnated with the test sample was assessed (8).

The results were calculated using the following equation, as the percentage of mortality, with reference to permethrin, as the standard drug at a concentration of 239.5 μg/cm2 as the positive control and volatile solvent as the negative control (7-8).

% Mortality = [1- (Number of insects alive in test/ Number of insects alive in –the negative control)] × 100

Anti-leishmanial activity bioassay

Leishmanialpromastigotes were cultured in a sterile 25 cm2 tissue culture flask containing buffered M-199 medium along with 25 mM HEPES (7) and 10% heat inactivated foetal bovine serum at pH 7.2 at 25 °C. Parasites were centrifuged at 3000 rpm, diluted with PBS and counted using a Neubauer chamber viewed under an optical microscope. Then, parasites were diluted with fresh medium to a concentration of 2×106 /mL. Stock samples were prepared by dissolving 1 mg in 50 μL DMSO and making the volume up to 1 mL with the culture medium. In the wells of a 96 well micro-titer plate, 90 μL of the parasite culture (2×106 /mL) along with 10 μL of different concentrations of stock samples (serial two fold dilutions) were added.

Ten μL of PBS (phosphate buffered saline, pH 7.2 containing 0.5% DMSO) was added as the negative control, while amphotricin B and pentamidine at a concentration of 1 mg/mL were added separately as the positive controls. The plate was incubated at 22 oC for 72 h, and the amount of parasites in each well was determined microscopically, using a Neubar chamber (7, 9).

Brine shrimp (Artemiasalina) cytotoxicity

For the brine-shrimp lethality assay, at first the artificial sea-water was prepared by adding sea-salt at a concentration of 3.8 g/L to double distilled water, followed by filtration of the resulting solution. Then the sea-water was poured into an aluminum foil covered tank, and 1 mg of shrimp eggs was added to this tank. Brine shrimp (Artemiasalina Leach) nauplii were hatched and matured after two days. Next, we selected some vials containing 1000, 100 and 10 μg/mL concentrations were prepared. After that stock sample solutions were prepared by dissolving 20 mg/2mL of samples in the volatile solvent, followed by the addition of 500, 50 and 5 μL of these stock solutions to different vials sequentially. After evaporation of the solvent, dried samples were again dissolved in 50 μL DMSO and 5 mL sea-water was added to make concentrations of 1000, 100 and 10 μg/mL, respectively. Ten shrimps were transferred to each sample vial and kept under illumination for 24 h. Finally, surviving shrimps were counted and data recorded were used to obtain LC50 and 95% confidence intervals (7).

Antifungal activity

For the evaluation of antifungal activities of test samples, they were tested against Candida albicans, Aspergillusflavus, Microsporumcanis, Fusariumsolani, and Candida glaberata, using the tube dilution protocol as the preliminary antifungal screening test. For preparation of test samples, 24 mg of samples were dissolved in 1 mL of sterile DMSO, serving as stock solutions. Sabouraud dextrose agar (SDA) was used for the growth of fungus. The acidic (pH value of 5.5 to 5.6) medium containing a relatively high concentration of glucose or maltose 2 was prepared, to give a concentration of 32.5 g/500 mL in distilled water. It was then steamed to dissolve the contents and dispensed in a known amount into screw cap tubes, followed by autoclaving at 121°C for 15 min. For loading the samples, tubes were allowed to cool to 50°C and non-solidified SDA was loaded with samples from the stock solution to make a final concentration of 400 μg/mL. Tubes were then allowed to solidify in a slanting position at room temperature. Each tube was inoculated with a 4 mm diameter piece of inoculum, removed from a seven day old fungal culture. For the non-mycelial growth, an agar surface streak was employed. Other media supplemented with DMSO and reference antifungal drugs were also prepared and used as the negative and positive controls, respectively. The tubes were incubated at 27-29°C for 7 days. Cultures were examined twice weekly during the incubation period. Evaluation of growth within the amended media was determined by measuring the linear growth (mm) and growth inhibition, calculated with reference to the negative control using the following formula:

% Inhibition of fungal growth = 100 – linear growth in test sample (mm) × 100 linear growth in control (mm)

The results were categorized as low (0-39%), moderate (40-59%), (60-69%) and significant (above 70%) activity, respectively.

The standard drugs used in the assays were miconazole and amphotericin B (7, 10).

Antibacterial bioassay

The agar well diffusion method was used as the preliminary screening test of in vitro antibacterial bioassay. In the first day a single colony of bacterial culture in nutrient broth was inoculated and incubated at 37°C for 24 h. Then, in the second day a soft agar tube was taken, melted and cooled up to 45°C, followed by the addition of 10 μL of fresh bacterial culture. After shaking and pouring it on to the nutrient agar containing plate, the plate was rotated to make even distribution of the culture and allowed to solidify. Wells were made by using 6 mm-diameter sterile borer and labeled with the sample code. Stock solutions of test samples (E2- E5) were prepared at a concentration of 3 mg/mL in DMSO (as solvent) and 100 μL of dilutions were poured into respective wells and other wells supplemented with DMSO and reference antibacterial drug (imipenem) at a concentration of 10 μg/mL/disc, serving as the negative and positive controls, and incubated at 37°C for 24 h. In the next day, results were noted in terms of the zone of inhibition in mm and interpreted, based on the following criteria: 0 = no activity, 9-11 mm = not significant, 12-14 mm = low activity, 15-17 mm = good activity, and above 18 mm = significant activity

Presence of antibacterial agent was indicated by the growth inhibition of the bacterial strains and appearance of zone of inhibition (observation of clear zone where the growth of bacteria had not occurred) (7).

Results

Phytotoxicity assay

Bioactivity of all the extracts (E2-E5) was investigated under the incubation condition of 28 ± 1°C and at three different concentrations of 1000, 100 and 10 μg/mL. Sample E2 appeared to have good phytotoxic activity, with 65% inhibition of the Lemna minor growth at a high concentration (1000 μg/mL) and moderate weedicidal activity at 100 μg/mL concentration. Other extracts (E3, E4 and E5) showed a moderate response (40-45%) at a concentration of 1000 μg/mL. All the samples were weakly active (5-10%) at a concentration of 10 μg/mL . The results of phytotoxic activity of the test compounds have been shown in Table 1.

Table 1.

In vitro phytotoxic bioassay of different fractions of Euphorbia Aellenniia

Samplesb Concentration (μg/mL) Number of fronds
%growth regulation Concentration of the standard drug (μg/mL)
Sample Control
E2 1000 9 20 65 0.015
E3 12 40
E4 11 45
E5 12 40
E2 100 15 20 35 0.015
E3 15 25
E4 14 30
E5 16 20
E2 10 18 20 15 0.015
E3 19 5
E4 19 5
E5 19 5

aStandard drug: Paraquat; number of replicates = 3; Incubation condition = 28 ± 1°C

bChloroform (E2), ethyl acetate (E3), n-butanolic (E4) and aqueous (E5) fractions.

Contact insecticidal toxicity

Three adult insects (Tribolium castaneum, Rhyzopartha dominica and Callosobruchus analis) were used for the direct contact insecticidal bioassay. Only one of the insects, Rhyzopertha dominica, showed acceptable mortality after treatment. E2 caused 45.56% mortality, determined as moderate activity. E3 and E4 showed 20% mortality, determined mortality. No activity was found with E5, against Rhyzopertha dominica. Other insects were not found to be susceptible to the tested compounds, as shown in Table 2.

Table 2.

Insecticidal activity obtained by the contact toxicity method on different fractions of Euphorbia Aellenniia

Name of Insect % Mortality
Positive control Negative control E2 b E3 E4 E5
Triboliumcastaneum 100 0 0 0 0 0
Rhyzoperthadominica 100 0 45 20 20 0
Callosbruchusanalis 100 0 0 0 0 0

aStandard drug: Premethrine; concentraion of sample = 1019 μg/cm2 and premethrine = 239 μg/cm2; number of replicates = 3.

bChloroform (E2), ethyl acetate (E3), n-butanolic (E4) and aqueous (E5) fractions.

Anti-leishmanial activity bioassay

In this bioassay method all assays were run in duplicate and amphotricin B and pentamidine (both at a concentration of 1 mg/mL), as well as the chloroform fraction of E. Aellenii (1 mg/mL) in DMSO, showed a growth inhibition effect on the Leishmania major promastigotes in a dose-dependent manner, while solvent did not have any effect. The IC50 value, indicating the effective concentration of compound in μg/mL necessary to achieve 50% growth inhibition, was found to be 140 ± 24 μg/mL. The value obtained for amphotricin B and pentamidine were 0.29 ± 0.05 μg/mL and 5.09 ± 0.04 μg/mL, respectively. While other samples (E3-E5) showed no significant activity.

Brine shrimp (Artemiasalina) cytotoxicity

LD50 measurements of E2-E5 fractions were investigated against Artemiasalina brine-shrimp eggs. Fraction E2, showed cytotoxicity at a concentration of 1000 μg/mL . E3 exhibited weak lethality, with a LD50 value of 770.66 μg/mL. Its lowest toxic concentration was found to be 74.07 μg /mL. Other test samples (E4 and E5), as shown in Table 4, found to be non-cytotoxic and had no significant lethality on brine shrimps. The results of cytotoxicity activity of the compounds are shown in Table 3.

Table 4.

In vitro antifungal bioassay (agar tube dilution protocol) results

Name of fungus Linear growth (mm)
% Inhibition
MIC of the standard drug
(μg/mL)
E2a E3 E4 E5 Negative control E2 E3 E4 E5 Negative control
Candida albicans 100 100 100 100 100 0 0 0 0 0 Miconazole (108.00)
Aspergillusflavus 100 100 100 100 100 0 0 0 0 0 Amphotericine B (20.02)
Microsporumcanis 100 100 100 100 100 0 0 0 0 0 Miconazole (98.40)
Fusariumsolani 75 74 74 100 100 25 26 26 0 0 Miconazole (73.25)

aChloroform (E2), ethyl acetate (E3), n-butanolic (E4) and aqueous (E5) ftions

bConcentration extraction of samples = 400 μg/mL of DMSO; replicates = 3; incubation period = 7 days; incubation temperature = 28 ± 1°C.

Table 3.

Brine shrimp (Artemiasalina) lethality bioassay of different partitions of Euphorbia Aellenii

Sample a Dose
(μg/mL)
Number of
shrimps
Number of
survivors
LD 50
(μg/mL)
Standard drug LD 50
(μg/mL)
E2b 1000 30 10 177.06 Etoposide 7.4625
100 30 18
10 30 21
E3 1000 30 19 770.66 Etoposide 7.4625
100 30 23
10 30 26
E4 1000 30 26 5346200 Etoposide 7.4625
100 30 27
10 30 28
E5 1000 30 24 377166.8 Etoposide 7.4625
100 30 26
10 30 28

aChloroform (E2), ethyl acetate (E3), n-butanolic (E4) and aqueous (E5) fractions.

bG (Probability value) = 0.48; No. of replicates: 3; Upper limit (upper toxic concentration) = 1878.68 μg/mL and lower limit (lower toxic concentration) = 42.38 μg/mL; incubation condition = 28 ± 1°C

Antifungal bioassay

E2, E3 and E4 fractions exhibited weak antifungal activities against Fusarium solani, with a fungal growth inhibition of about 25-26% (Table 5). Whereas , the result of aqueous fraction (E5) was not significant. None of the tested compounds were found to be active against Candida albicans, Aspergillus flavus, Microsporum canisand Candida glabrata, when using a concentration of 400 μg/mL of the test samples (Table 4).

Antibacterial bioassay

The antibacterial study was performed against Escherichia coli, Bacillus subtilis, Shigella flexenari, Staphylococcus aureus, Pseudomonas aeruginosa and Salmonella typhi. The data obtained, showed that samples E2, E3, E4 and E5 were totally ineffective.

Discussion

Chloroform fraction of the methanolic extract of Euphorbia Aelleniiappeared to have good phytotoxic activity at a concentration of 1mg/mL and moderate weedicidal activity at a concentration of 100 μg/mL . The other fractions (ethyl acetate, butanolic and aqueous) showed moderate response (40-45%) at a concentration of 1000 μg/mL and low activity in lower concentrations. In the case of Euphorbia wallichi, as reported by Irshad Ali and co-workers, chloroform and ethyl acetate fractions showed significant activity at a concentration of 100 μg/mL (11). However, in a research conducted on Euphorbia helioscopiaby Uzair et al., the crude methanolic extract had non-significant phytotoxicity against Lemna minor (12). These data would suggest the potential of the chloroform fraction for further phytochemical analysis, as a potent herbicide.

The chloroform fraction of Euphorbia Aellenii(1 mg/mL) in DMSO, showed agrowth inhibitory effect on Leishmania major promastigotes, with an IC50 value of 140 ± 24 μg/mL compared with amphotricin B (0.29 ± 0.05 μg/mL) and pentamidine (5.09 ± 0.04 μg/mL). In fact, samples with IC50 values greater than 25 μM are considered to be weakly active. However, based on the results obtained from the extract, it is proposed that the active leishmanicidal components may be present in very low amounts, and suggesting the need for purification of secondary metabolites in order to achieve a more favorable leishmanicidal activity (7). In a study conducted by Ja’fari and co-workers at 2005 on Euphorbia myrsinites, the methanolic extract at a concentration of 1 mg/mL had favorable leishmanicidal activity and killed the Leishmania major promastigotes in a dose-dependent manner, with an EC50 value between 0.5 and 0.25 mg/mL (9). In another research on Euphorbia lagascae(13), stilbenes possessed moderate anti-leishmanial activity against promastigotes and also taxane type diterpenoids, which are structurally similar to myrisinane type diterpenoids, present in the Euphorbia genera had shown anti-leishmanial activity (14). Some cycloartane type triterpenes have also shown anti-leishmanial activity (15) and due to the presence of phenolic compounds like stilbenes, myrisinane type diterpenoids and cyloartanes in the Euphorbia genus, the anti-leishmanial activity could be related to these types of compounds.

In the insecticidal bioassay, the chloroform fraction caused moderate activity and ethyl acetate and butanolic fractions had weak mortality against only one of the insects, Rhyzopertha dominica. In a study by Civelek and Weintaub, Euphorbia myrsinites showed acceptable insecticidal activity (16). Furthermore, in traditional medicine Euphorbia has been used in the treatment of intestinal parasites and as pesticide (2). These data candidate the chloroform fraction for further phytochemical analysis, in order to discover new compounds with insecticidal activity.

This study also showed in the cytotoxicity activity of the chloroform fraction of Euphorbia aellenii, which was comparable with the chloroform fraction of Euphorbia wallichi (11). This rather good cytotoxicity effect was seen at a high concentration of 1000 μg/mL, in compliance with many other literature reports on the genus Euphorbia for cytotoxic effect due to the presence of diterpenoid polyesters. Based on this study, it is recommended to purify and isolates the diterpenoid polyesters, as a good candidate for anticancer activity, and compare it with taxol and deacetyl-baccatine as known diterpenoid anticancer drugs, and other diterpenoids found in Euphorbiaceae.

In terms of the antifungal screening test, all the fractions exhibited rather low percentage of fungal growth inhibition against Fusariumsolani. However, in a similar work on Euphorbia wallichii, no significant antifungal activity was observed for the tested fungi (11).

The result of antibacterial screening was totally negative while antibacterial study performed against bacteria on ethyl acetate partition of E. wallichi(11) and ethanolic extract of E. peplus(17) have showed antibacterial activity. In traditional medicine also there are some reports of using euphorbia against some bacterial infections like gonorrhea (2) thus, the negative result may be due to a resistance to this type of constituents.

Acknowledgements

This paper is part of the thesis of Syed Mustafa Ghanadian submitted for the fulfillment of the degree of doctor of philosophy in Pharmacognosy in Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran and the authors are grateful to the H.E.J International Center of Chemical and Biological Sciences through their scientific and financial supports

References

  • 1.Heywood VH. Flowering Plants of the World . London : BT Batsford Ltd; 1998. pp. 183–187. [Google Scholar]
  • 2.Jassbi AR. Structure elucidation and chemistry of novel diterpenoids from Euphorbia plants of Iran. Iranian J. Pharm. Res. 2004:87–87. Supplement 2. [Google Scholar]
  • 3.Ayatollahi SAM, Shojaii A, Kobarfard F, Choudhary MI. Terpens from aerial parts of Euphorbia splendida. J. Med. Plants Res. 2009;3:660–665. [Google Scholar]
  • 4.Fata A, Elahi R, Haririzadeh G. In vitro study of the effect of juice and extract of Euphorbia myrciniteson promastigotes in N. N. N. medium. J. Mashhad Univ. Med. Sci. 1993;36:30–36. [Google Scholar]
  • 5.Evans WC. Trease and Evans’ Pharmacognosy. London : W. B. Saunders; 2002. pp. 322–474. [Google Scholar]
  • 6.Ghahreman A. Flora of Iran. Vol. 24. Tehran : Research Institute of Forests and Rangelands Publications; No. 2958. [Google Scholar]
  • 7.Atta-ur-Rahman , Choudhary MI, Thomson WJ. Bioassay Techniques for Drug Development. Amsterdam : Tylor& Francis; 2001. pp. 7–72. [Google Scholar]
  • 8.Yingjuan Y, Wanlun C, Changju Y, Dong X, Yanzhang H. Isolation and characterization of insecticidal activity of (Z)-asarone from AcoruscalamusL. Insect Sci. 2008;15:229–236. [Google Scholar]
  • 9.Jaafari MR, Behravan J, Bodagh-abadi , Ramezani M. Evaluation of leishmanicidal effect of Euphorbia myrsinitesextract by in vitro antileishmanial assay using promastigote of Leishmania major. IJBMS. 2005;8:294–298. [Google Scholar]
  • 10.Rashid R, Mukhtar F, Mohammad-niaz M. Biological screening of Salvia cabulica. Pak. J. Bot. 2009;41:1453–1462. [Google Scholar]
  • 11.Irshad A, Rubina N, Wahib NK, Rukhsana G, Choudhary MI. Biological screening of different root extracts of Euphorbia wallichii. Pak. J. Bot. 2009;41:1737–1741. [Google Scholar]
  • 12.Uzair M, Loothar BA, Choudhary MI. Biological screening of Euphorbia helioscopiaL. Pak. J. Pharm. Sci. 2009;22:184–186. [PubMed] [Google Scholar]
  • 13.Duarte N, Kayser O, Abreu P, Ferreira MJ. Antileishmanial activity of piceatannol isolated from Euphorbia lagascaeseeds. Phytother. Res. 2008;22:455–457. doi: 10.1002/ptr.2334. [DOI] [PubMed] [Google Scholar]
  • 14.Georgopoulou K, Smirlis D, Bisti S, Xingi E, Skaltsounis L, Soteriadou K. In vitro activity of 10-deacetylbaccatin III against Leishmaniadonovanipromastigotes and intracellular amastigotes. Planta Med. 2007;73:1081–1087. doi: 10.1055/s-2007-981579. [DOI] [PubMed] [Google Scholar]
  • 15.Choudhary MI, Saleem J, Abbaskhan A, Musharraf SG, Samreen , Sattar SA, Atta-ur-Rahman Cycloartanetriterpenoids from Astragalusbicuspis. J. Nat. Prod. 2008;71:1557–1560. doi: 10.1021/np800161j. [DOI] [PubMed] [Google Scholar]
  • 16.Civelek HS, Weintraub PG. Effects of two plant extracts on larval leafminerLiriomyzatrifolii(Diptera: Agromyzidae) in tomatoes. J. Econ. Entomol. 2004;97:1581–1586. doi: 10.1603/0022-0493-97.5.1581. [DOI] [PubMed] [Google Scholar]
  • 17.Oskay M, Oskay D, Kalyoncu F. Activity of some plant extracts against multi-drug resistant human pathogens. Iranian J. Pharm. Res. 2009;8:293–300. [Google Scholar]

Articles from Iranian Journal of Pharmaceutical Research : IJPR are provided here courtesy of Brieflands

RESOURCES